Alpine Immune Sciences, Inc.(Deutsche Boerse AG : NVLS)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| CELG | Celgene Corporation | -1.05% | 87.30 | 1.3% | $1275.26m | |
| AMGN | Amgen Inc. | -0.25% | 198.89 | 1.2% | $667.61m | |
| GILD | Gilead Sciences, Inc. | -1.28% | 67.64 | 0.9% | $577.79m | |
| BIIB | Biogen Inc. | -1.63% | 332.03 | 1.3% | $485.41m | |
| LOXO | Loxo Oncology Inc | -0.18% | 233.26 | 12.7% | $449.60m | |
| ILMN | Illumina, Inc. | 0.05% | 305.63 | 3.5% | $350.96m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -0.28% | 186.15 | 1.9% | $318.23m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.12% | 404.54 | 2.6% | $308.69m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.03% | 111.70 | 2.0% | $229.47m | |
| TSRO | TESARO, Inc. | 0.03% | 74.88 | 14.4% | $201.67m | |
| A | Agilent Technologies, Inc. | -0.82% | 70.02 | 1.5% | $164.25m | |
| EXAS | Exact Sciences Corporation | -2.75% | 74.97 | 25.3% | $151.07m | |
| INCY | Incyte Corporation | -2.79% | 76.56 | 2.5% | $146.84m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.45% | 119.26 | 15.4% | $142.24m | |
| LGND | Ligand Pharmaceuticals Incorporated | -16.48% | 110.05 | 23.1% | $105.44m |
Company Profile
Alpine Immune Sciences, Inc. is a development-stage pharmaceutical company, which engages in the discovering of protein-based immunotherapies therapies targeting the immune synapse to treat cancer, autoimmune, and inflammatory disorders. It offers Immunotherapy, Immune Synapse, vIgD Platform Technology, and TIP Program. The company was founded on July 24, 2017 and is headquartered in Seattle, WA.